. Author manuscript; available in PMC: 2014 Jun 1.

Published in final edited form as: Arthritis Rheum. 2013 Jun;65(6):1421–1429. doi: 10.1002/art.37917

Table 1.

Mean adherence during the 2-year follow-up for individual DMARDS and prednisone

	Methotrexate	Leflunomide	Hydroxy- chloroquine	Sulfasalazine	All DMARDs	Prednisone
Number of patients who received the prescribed drug	76	35	29	8	107	56
Prescribed days, mean (SD)	650 (185)	503 (255)	637 (205)	577 (242)	591 (198)	603 (230)
Days under electronic monitoring mean (SD)	451 (254)	379 (269)	494(245)	303 (334)	421 (247)	437 (263)
% Doses taken as prescribed mean^* (SD)	63(20)	71(18)	63 (23)	58 (29)	64 (19)	70 (20)
% Underdosing mean^* (SD)	22(18)	24(16)	34 (23)	41 (30)	26 (19)	27 (20)
% Overdosing mean^* (SD)	14(10)	4 (8)	2 (2)	1 (2)	9 (8)	3 (2)

Only one patient using azathioprine was monitored (not showed in the table). All DMARDs: Patients receiving at least one DMARD.

mean of the % doses taken by each patient for each drug.